Advances include improved access to prophylaxis, multiple subcutaneous drugs in development, and research looking at better ways to personalize treatment.
For too many people with a bleeding disorder, pain isn’t well-managed. The landmark Haemophilia Experiences, Results and Opportunities (HERO) international...